David Vydra
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Natural product bioactivities and synthesis 2
-
- Pharmacological Effects and Toxicity Studies 1
- Co-authors
- Marián Hajdúch (5 shared papers)Petr Džubák (3 shared papers)Jan Šarek (2 shared papers)David Biedermann (2 shared papers)Miroslav Kvasnica (2 shared papers)Milan Urban (2 shared papers)Lenka Marková (2 shared papers)Karel Doležal (1 shared paper)
- Journals
- Journal of Crohn s and Colitis (1 paper)Journal of Chromatography A (1 paper)Natural Product Reports (1 paper)Cancer Genetics and Cytogenetics (1 paper)PubMed (2 papers)
- Partner nations
- Czechia
In The Last Decade
David Vydra
7 papers receiving 668 citations
David Vydra's Hit Papers
Peers
Comparison fields: 5 of 82
- Toxicology 75
- Pharmacology 104
- Molecular Biology 533
- Biochemistry 37
- Plant Science 159
Countries citing papers authored by David Vydra
This map shows the geographic impact of David Vydra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vydra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vydra more than expected).
Fields of papers citing papers by David Vydra
This network shows the impact of papers produced by David Vydra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vydra. The network helps show where David Vydra may publish in the future.
Co-authors
The 25 scholars most cited alongside David Vydra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacological activities of natural triterpenoids and their therapeutic implications Hit paper breakdown → | 2006 | 584 |
| 2 | 2005 | 26 | |
| 3 | 2006 | 23 | |
| 4 | 2010 | 19 | |
| 5 | Heart rate variability in children with inflammatory bowel diseases. | 2015 | 13 |
| 6 | Quality of life in adolescents with inflammatory bowel disease and their parents--comparison with healthy controls. | 2015 | 12 |
| 7 | In vivo mode of action of CYC116, a novel small molecule inhibitor of Aurora kinases and VEGFR2 | 2008 | 11 |
| 8 | Léčebná výživa u dětí | 2013 | 0 |
| 9 | 2014 | 0 |
About David Vydra
David Vydra is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health, Organic Chemistry and Surgery, having authored 9 papers that have together received 688 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (2 papers), Intestinal Malrotation and Obstruction Disorders (1 paper), Child Nutrition and Feeding Issues (1 paper), Pharmacological Effects of Medicinal Plants (1 paper), Cancer Genomics and Diagnostics (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Genetic factors in colorectal cancer (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Toxicology (75 citations), Pharmacology (104 citations), Molecular Biology (533 citations), Biochemistry (37 citations) and Plant Science (159 citations). David Vydra has collaborated with scholars based in Czechia. Frequent co-authors include Marián Hajdúch, Petr Džubák, Jan Šarek, David Biedermann, Miroslav Kvasnica, Milan Urban, Lenka Marková, Karel Doležal, Ján Praško and Igor Popa. Their work appears in journals such as Journal of Crohn s and Colitis, Journal of Chromatography A, Natural Product Reports, Cancer Genetics and Cytogenetics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.